FDA - Food and Drug Administration
FDA clears AI model to triage urgent CT findings, Israeli firm says
Aidoc won FDA clearance for a 'foundation model' clinical AI that triages 14 abdomen-CT indications in one workflow, aiming to surface urgent findings faster amid ED crowding and imaging backlogs.
FDA clears first US trial of Israel’s EndoArt synthetic corneal implant
Arizona couple admits in court to faking cancer-curing 'smart chip' device
Forget the injections: The FDA has approved a daily weight-loss pill for the first time
US FDA clears Moderna and J&J boosters
The decision paves the way for millions more people in the US to get the additional protection with the highly contagious Delta variant of the virus causing breakthrough infections.
Generic, cancer-killing Israeli drug approved for marketing by FDA
The drug, and the company that makes it, is located in Jerusalem and was developed by Prof. Yechezkel Barenholz.
FDA to allow mix and match of COVID-19 booster vaccines- NYT
The government would not recommend one shot over another, and it might note that using the same vaccine as a booster when possible is preferable, the NYT report said.
COVID-19: FDA advisers back Moderna booster shots for older and high-risk people
The CDC will make specific recommendations on who should get the booster shots.
COVID: mRNA booster dose generates stronger antibody response after J&J shot
New data shows that those who get an mRNA jab after the Johnson & Johnson vaccine will have a stronger antibody response.
Israel's DreaMed gets FDA clearance for diabetes solution
Israeli company DreaMed Diabetes AI developed Advisor Pro, a decision support system to assist healthcare providers in the management of diabetes patients with insulin pumps or injections.
FDA decision to limit COVID booster shots didn't satisfy anyone - opinion
The FDA approved the COVID-19 booster shot only for high-risk patients and people over 65, which is not the answer Pfizer, the US and Israel wanted to hear.
US eyes IDF soldiers' data for Pfizer COVID-19 booster safety
US health officials are hoping data on Israeli military personnel can help clarify the risk of heart muscle inflammation in younger people who have received Pfizer/BioNTech COVID-19 booster shots.
Pfizer seeks FDA clearance for COVID-19 vaccine in younger children
The vaccine, which is already authorized in teens aged 12 to 15 and fully approved for ages 16 and up, has been shown to induce a strong immune response in the target age group.
COVID-19: FDA to authorize Pfizer booster vaccine for older Americans
Advisers to the FDA voted on Friday to recommend COVID-19 vaccine booster shots for Americans 65 and older.
